BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26445507)

  • 1. Differences in Metabolic Programming Define the Site of Breast Cancer Cell Metastasis.
    Döppler H; Storz P
    Cell Metab; 2015 Oct; 22(4):536-7. PubMed ID: 26445507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
    Dupuy F; Tabariès S; Andrzejewski S; Dong Z; Blagih J; Annis MG; Omeroglu A; Gao D; Leung S; Amir E; Clemons M; Aguilar-Mahecha A; Basik M; Vincent EE; St-Pierre J; Jones RG; Siegel PM
    Cell Metab; 2015 Oct; 22(4):577-89. PubMed ID: 26365179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis.
    Hinton CV; Avraham S; Avraham HK
    J Cell Mol Med; 2008; 12(5A):1517-26. PubMed ID: 18363848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis suppression by adiponectin: LKB1 rises up to the challenge.
    Saxena NK; Sharma D
    Cell Adh Migr; 2010; 4(3):358-62. PubMed ID: 20418665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new key in breast cancer metastasis.
    Benovic JL; Marchese A
    Cancer Cell; 2004 Nov; 6(5):429-30. PubMed ID: 15542424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.
    Imanishi Y; Hu B; Xiao G; Yao X; Cheng SY
    J Biol Chem; 2011 Aug; 286(33):29249-29260. PubMed ID: 21680733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway.
    Imanishi Y; Hu B; Jarzynka MJ; Guo P; Elishaev E; Bar-Joseph I; Cheng SY
    Cancer Res; 2007 May; 67(9):4254-63. PubMed ID: 17483337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting lemurs against cancer metastasis.
    Xu Y; Zhang H; Giamas G
    Oncotarget; 2014 Jul; 5(14):5192-3. PubMed ID: 25114035
    [No Abstract]   [Full Text] [Related]  

  • 11. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
    Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
    Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
    Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
    Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer.
    Jeong SB; Im JH; Yoon JH; Bui QT; Lim SC; Song JM; Shim Y; Yun J; Hong J; Kang KW
    Mol Cancer Ther; 2018 Apr; 17(4):825-837. PubMed ID: 29437878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM suppresses SATB1-induced malignant progression in breast epithelial cells.
    Ordinario E; Han HJ; Furuta S; Heiser LM; Jakkula LR; Rodier F; Spellman PT; Campisi J; Gray JW; Bissell MJ; Kohwi Y; Kohwi-Shigematsu T
    PLoS One; 2012; 7(12):e51786. PubMed ID: 23251624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer.
    Yang L; Li N; Xue Z; Liu LR; Li J; Huang X; Xie X; Zou Y; Tang H; Xie X
    Cell Death Differ; 2020 Jul; 27(7):2066-2080. PubMed ID: 31969692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells.
    Jung S; Ohk J; Jeong D; Li C; Lee S; Duan J; Kim C; Lim JS; Yang Y; Kim KI; Lee MS
    Int J Oncol; 2014 Jul; 45(1):189-96. PubMed ID: 24789658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors.
    Maroni P; Matteucci E; Bendinelli P; Desiderio MA
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28045433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
    Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer.
    El-Sahli S; Wang L
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
    Salah Z; Itzhaki E; Aqeilan RI
    Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.